1982
DOI: 10.1016/0306-4530(82)90011-7
|View full text |Cite
|
Sign up to set email alerts
|

Effects of lysine-vasopressin and 1-deamino-8-d-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
14
1

Year Published

1983
1983
2013
2013

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 56 publications
(16 citation statements)
references
References 14 publications
1
14
1
Order By: Relevance
“…Thus in a study by Gilot et al (1980) amnesic performances of patients suffering from diabetes insipidus were reported to improve after treatment with a synthetic vasopressin (DDAVP), but since this drug also eliminates the need to wake up at night to urinate an alternative interpretation of the improved memory performance in terms of better sleep cannot be ruled out. Another study conducted by Laczi et al (1982) failed to provide a proper control group against which to compare the performance of the treatment group. In other studies it is questionable whether the treatment group was homogenous enough to allow a fair evaluation of a drug which might not be equally effective in dealing with all forms of amnesia.…”
mentioning
confidence: 99%
“…Thus in a study by Gilot et al (1980) amnesic performances of patients suffering from diabetes insipidus were reported to improve after treatment with a synthetic vasopressin (DDAVP), but since this drug also eliminates the need to wake up at night to urinate an alternative interpretation of the improved memory performance in terms of better sleep cannot be ruled out. Another study conducted by Laczi et al (1982) failed to provide a proper control group against which to compare the performance of the treatment group. In other studies it is questionable whether the treatment group was homogenous enough to allow a fair evaluation of a drug which might not be equally effective in dealing with all forms of amnesia.…”
mentioning
confidence: 99%
“…ANP is known to have strong anxiolytic effects and specific actions on different levels of the hypothalamus-pituitary-adrenocortical (HPA) axis [6,7], such as inhibition of corticotropin-releasing hormone (CRH), adrenocorticotropin (ACTH) and cortisol secretion [8]. Contrary to that, AVP is known to enhance memory function and has been proposed to exert anxiogenic effects [9,10] as well as stimulate CRH and ACTH expression at both the hypothalamic and pituitary levels [11]. Furthermore, studies have demonstrated that AVP is implicated in appetite regulation [12] as well as depression and obsessive behavior [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…AVP and related peptides improve memory functions in healthy subjects (Laczi et al 1982a;Legros et al 1978; Legros & Gilot 1979), in diabetes insipidus (DI) patients (Laczi et al 1982a;Gilot et al 1980), in depressed patients (Weingartner et al 1981) and in patients suffering from some but not all amne¬ stic syndromes (Drago et al 1981; Le Boeuf et al 1978;Oliveros et al 1978;Timsit-Berthier et al 1979; Koch-Henriksen & Nielsen 1981;Jenkins et al 1979). [Lys8]-vasopressin (LVP) or 1-desamino-[D-Arg8]-vasopressin (DDAVP) were used in near¬ ly all these studies. We observed however that DGAVP improved memory processes in healthy subjects and in DI patients (Laczi et al 1982b al.…”
mentioning
confidence: 99%